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Many biomedical applications absolutely require, or are substantially enhanced by, coexpression of multiple proteins from a single
vector. Foot-and-mouth disease virus 2A (F2A) and “2A-like” sequences (e.g.,Thosea asigna virus 2A; T2A) are used widely for this
purpose since multiple proteins can be coexpressed by linking open reading frames (ORFs) to form a single cistron.The activity of
F2A “cleavage”may, however, be compromised by both the use of shorter versions of F2A and the sequences (derived frommultiple-
purpose cloning sites) used to link F2A to the upstream protein. To characterise these effects, different lengths of F2A and T2Awere
inserted between green and cherry fluorescent proteins. Mutations were introduced in the linker region immediately upstream of
both F2A- and T2A-based constructs and activities determined using both cell-free translation systems and transfected cells. In
shorter versions of F2A, activity may be affected by both the C-terminal sequence of the protein upstream and, equally strikingly,
the residues immediately upstream introduced during cloning. Mutations significantly improved activity for shorter versions of
F2A but could decrease activity in the case of T2A. These data will aid the design of cloning strategies for the co-expression of
multiple proteins in biomedical/biotechnological applications.
1. Introduction
Many biomedical applications require vectors that can direct
the expression of multiple proteins; subunits of hetero-multi-
meric proteins, multiple therapeutic genes (combined and/or
synergistic effects), or, simply, coexpression of a therapeutic
protein along with proteins that act as (selectable) markers
of transformed cells [1, 2]. A number of approaches are used
to coexpress multiple genes, including fusion proteins (which
may include proteinase cleavage sites), alternative mRNA
splicing, multiple promoters, reinitiation of translation, and
internal ribosome entry sites (IRESes). Each, however, has
associated disadvantages: fusion proteins localise to only
a single subcellular site, while steric hindrance may alter
their function. If a proteinase cleavage site is incorporated,
this requires colocalisation of the substrate and processing
enzyme in the same subcellular site. Internal promoters
frequently show interference or are downregulated, while
expression from IRESes (dependent on various cellular bind-
ing factors) varies between different cell types. Although
derived from a single bicistronic mRNA, expression of
the downstream ORF (IRES-driven cap-independent trans-
lation) is typically ∼10% of that of the upstream ORF (cap-
dependent translation). IRES elements, identified both in
viral and cellular eukaryotic mRNAs, differ in nucleotide
length (from 130 bp to 1 kb). However, the most efficient viral
IRESes successfully utilized in vectors used for biomedical
purposes are about 500 bp in length. Their comparatively
large size can be a limiting factor when using virus-based
vectors which have limited coding capacity: adeno-associated
vectors cannot package more than ∼5 kb efficiently, whilst
retroviral vectors can package only ∼7-8 kb [1–7].
Foot-and-mouth disease virus 2A (F2A) and “2A-
like” sequences have become a useful alternative to these
approaches since multiple proteins can be coexpressed at
equimolar amounts from a single transcriptmRNAunder the
control of a single promoter. 2A mediates a cotranslational
“ribosome skipping” event (for simplicity referred to as
“cleavage”), to produce the C-terminus of 2A. Interestingly,
the length of 2A in the FMDV polyprotein (18aa) is defined
by the site of the skipping event (forming the C-terminus
of F2A), plus the N-terminus delineated by the site where
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a virus-encoded proteinase (3Cpro) trims “2A” from the
upstream capsid protein 1D at a later stage in virus replication.
We have shown, however, that the functional length of “2A”
actually incorporates (capsid protein 1D) sequences upstream
of 2A.The longer versions of 2Adescribed below are therefore
2A plusN-terminal extensions of the upstream capsid protein
1D, but for simplicity referred to as F2A [8–11].
The major advantages of using the 2A system in the
construction of multicistronic vectors are (i) its small size
(54–174 bp) compared to IRESes, (ii) that coexpression of
proteins linked by 2A is independent of the cell type (since
cleavage activity is only dependent on eukaryotic ribosomes,
structurally highly conserved amongst the eukaryota), and
(iii) that multiple 2As may be used, the activity of each
being completely independent. In the case of F2A, it was
demonstrated that although good cleavage was observed
using the 19aa version, the use of longer versions of 2A was
reported to produce higher levels of cleavage [8–11].
While the F2A sequence has been used widely, many
“2A-like” sequences have been utilized successfully, includ-
ing equine rhinitis A virus (E2A), porcine teschovirus-1
(P2A), andThosea asigna virus (T2A) [9–17].These “2A-like”
sequences have been used in adoptive cell therapies [12, 14,
15], genetic engineering of human stem cells [16, 18, 19], and
the coexpression of transcription factors in the induction of
pluripotent stem cells [17, 20–23].
To date, F2A sequences of various lengths have been
utilised in biotechnology, from 18 to 58aa [24–31]. In het-
erologous (artificial polyprotein) contexts, the 2A sequence
remains as a C-terminal extension of the upstream gene:
potentially a consideration when using longer, albeit more
efficient, F2A sequences. C-terminal extensions may affect
protein conformation, whilst an “authentic” C-terminus may
be crucial for activity or for posttranslational modification.
Shorter versions of 2A have been used, although often at the
expense of cleavage efficiency [9, 12, 24, 27, 28]. In the case
of proteins entering the exocytic pathway, C-terminal exten-
sions of 2Amay be “trimmed” away by the incorporation of a
furin cleavage site between the upstream protein and 2A [24,
32]. Furthermore, it has been reported that in some cases the
efficiency of 2A cleavage may be greatly inhibited when coex-
pressing certain proteins targeted to the exocytic pathway. C-
terminal sequences of the upstream gene were implicated to
be responsible for these lower levels of cleavage [33].
To further optimise the 2A coexpression system, we used
T2A and shorter versions of F2A inserted between GFP and
CherryFP fluorescent “reporter” proteins. Mutations were
introduced into the region immediately upstream of both
F2A- and T2A-based constructs. The effects on activity were
determined using both cell-free coupled transcription/trans-
lation systems in vitro and in transfected HeLa cells, a human
cell line most commonly used in biomedical applications.
Activity can be affected in two ways: (i) by the C-terminal
region of the protein upstream of F2A (where shorter F2As
are utilised) and, significantly, (ii) by the short amino acid
tract linking the protein upstream with F2A introduced by
the cloning strategy. In the case of shorter versions of F2A,
in some cases mutation significantly increased activity. Con-
versely, in the case of the highly active T2A, some mutations
decreased activity. Taken together, these data show that
sequences within 30–40aa upstream of the cleavage site may
be highly influential in determining 2A activity: particular
care should be taken in this aspect in the design of constructs
for coexpression of multiple proteins prior to their further
development in biomedical applications.
2. Materials and Methods
The following reagents were obtained from commercial sup-
pliers: Pfu polymerase, T4 DNA ligase, restriction enzymes,
JM109 competent cells, and Quick TnT rabbit reticulocyte
lysate kit (Promega, Madison, WI, USA); 35S methionine
(MP Biomedicals, Santa Ana, CA, USA); EDTA-free protease
inhibitor cocktail (Sigma-Aldrich Company Ltd, Dorset,
UK); pcDNA3.1, anti-RFP, rabbit purified polyclonal anti-
body against Red Fluorescent Protein (1 : 1000 dilution), anti-
GFP, mAb 3E6, anti-Green Fluorescent Protein, mouse mon-
oclonal antibody (1 : 1000 dilution), anti-𝛽-tubulin, mouse
monoclonal antibody (1 : 2000 dilution), Lipofectamine2000
transfection reagent, iBlot Gel Transfer Stacks, and nitro-
cellulose (Life Technologies Ltd., Paisley, UK); secondary
HRP-conjugated polyclonal goat antimouse and antirabbit
antibodies (DakoUKLtd., Ely, UK); EZ-ECLChemilumines-
cence Detection Kit for HRP (Geneflow Ltd., Elmhurst, UK);
and Oligonucleotides were purchased from Integrated DNA
Technologies (Coralville, IA, USA).
2.1. Construction of Plasmids
pGFP-F2As-CherryFP Plasmid Construct Series. Here, F2As
of various lengths (58, 30, 25–20, and 18aa) were inserted
between sequences encoding GFP and CherryFP (Table 1).
To make the pGFP-F2A
58
-CherryFP construct, the sequence
encoding the 58aa version of F2A was obtained by digesting
pSV7 plasmid (kind gift of Sandra Vater) with NsiI and
ApaI. This insert was then used to replace the TaV 2A in
pJC3, similarly restricted. Plasmid pGFP-F2A
58
-CherryFP
was then used as a template to produce further truncated
forms of F2A. Briefly, different lengths of F2A were amplified
by PCR, creating an XhoI site at the N-terminus and a NotI
site present downstream of the CherryFP in both plasmids.
Forward oligonucleotides incorporating the XhoI restriction
site (underlined)
5󸀠-GCGCTCGAGCACAAACAGAAAATTGTG-
GCACCGGTG-3󸀠for F2A
30
,
5󸀠-GCGCTCGAGGTGGCACCGGTGAAACAG-
ACTTTG-3󸀠 for F2A
25
,
5󸀠-GCGCTCGAGGCACCGGTGAAACAGACT-
TTG-3󸀠 for F2A
24
,
5󸀠-GCGCTCGAGCCGGTGAAACAGACTTTG-
AATTTTG-3󸀠 for F2A
23
,
5󸀠-GCGCTCGAGGTGAAACAGACTTTGAAT-
TTTGAC-3󸀠 for F2A
22
,
5󸀠-GCGCTCGAGAAACAGACTTTGAATTTT-
GACCTTC-3󸀠 for F2A
21
,
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Table 1: Upstream, linker and F2A and T2A sequences in pGFP-2A-Cherry constructs.
GFP    Linker FMDV1D FMDV 2A    
VTAAGITLGMDELYKMHGRAKRSLEHKQKIVAPVKQTLNFDLLKLAGDVESNPG P   
VTAAGITLGMDELYKMHGRAKRSLE VAPVKQTLNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHGSGSRGAC VAPVKQTLNFDLLKLAGDVESNPG P   
VTAAGITLGMDELYKMHGRAKRSLE APVKQTLNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHGSGSRGAC APVKQTLNFDLLKLAGDVESNPG P      
VTAAGITLGMDELYKMHGRAKRSLE PVKQTLNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHGSGSRGAC PVKQTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGRAKRSLE VKQTLNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHGSGSRGAC VKQTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGRAKRSLE KQTLNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHGSGSRGAC KQTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGRAKRSLE QTLNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHGSGSRSLE QTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGRAKRGAC QTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGSGSRGAC QTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGAAKASLE QTLNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGRAKRSLE LNFDLLKLAGDVESNPG P 
VTAAGITLGMDELYKMHGSGSRGAC LNFDLLKLAGDVESNPG P  
VTAAGITLGMDELYKMHGAAKASLE LNFDLLKLAGDVESNPG P
VTAAGITLGMDELYKMHSRGSG EGRGSLLTCGDVEENPG P
VTAAGITLGMDELYKMHSRSLE EGRGSLLTCGDVEENPG P
VTAAGITLGMDELYKRAKRSLE EGRGSLLTCGDVEENPG P
30aa        
25aa        
25aa mut    
24aa        
24aa mut    
23aa        
23aa mut    
22aa        
22aa mut    
21aa        
21aa mut    
20aa        
20aa mut1    
20aa mut2   
20aa mut3  
20aa Fmut   
18aa        
18aa mut    
18aa Fmut   
T2A wt      
T2A mut1
T2A mut2
5󸀠-GCGCTCGAGCAGACTTTGAATTTTGAC-
CTTCTCAAG-3󸀠 for F2A
20
,
5󸀠-GCGCTCGAGTTGAATTTTGACCTTCTC-
AAGTTGGCG-3󸀠 for F2A
18
and a reverse oligonucle-
otide (5󸀠-TAGAAGGCACAGTCGAGGC-3󸀠, binds
∼70 nts downstream of the NotI site) were used to
amplify F2As-CherryFP with 2As of various lengths.
The PCR products were digested with XhoI and NotI
and cloned into pGFP-F2A
58
-CherryFP, similarly
restricted.
pGFP-F2As-CherryFP Mutant Constructs. Truncated and
mutated forms of F2A are shown in Table 1. These forms
were produced by recombination in competent JM109 cells
of two PCR products. The first was amplified with for-
ward primer encoding the mutated sequences and a reverse
primer binding to the vector backbone at nt 4500 (5󸀠-
GTTCCACTGAGCGTCAGACCCCGTAG-3󸀠). The second
was amplified using a reverse primer encoding the mutated
sequence and a forward primer binding to the vector
backbone at nt 4500 (5󸀠-CTACGGGGTCTGACGCTC-
AGTGGAAC-3󸀠). Forward and reverse primer sets for
each construct are shown in Table S1 (see Table S1 in the
species list in the Supplementary Material available online at
http://dx.doi.org/10.1155/2013/291730).
2.2. Transcription and Translation. Plasmid constructs were
used to programme Quick TnT transcription/translation
reticulocyte lysate systems (Promega). Translation reactions
(10 𝜇L) were performed according to the manufacturer’s
instructions. Briefly, 20 ng of plasmid DNA was used to pro-
gramme rabbit reticulocyte lysates containing 35Smethionine
(10 𝜇Ci) and incubated at 30∘C for 1 h. Translation reactions
were stopped by the addition of 2x protein sample buffer.
Protein products were analysed by 12% SDS-PAGE.
2.3. Expression in HeLa Cells. HeLa cells were maintained
in DMEM medium supplemented with 10% FCS. The cells
were transfected in 60mm dishes (preplated 20 h earlier to
60% confluency) with 1.5 𝜇g of plasmid DNA and 7 𝜇L of
Lipofectamine2000 (Invitrogen) in a final volume of 400𝜇L
OptiMEM. Transfectionmix was added to 2mL of antibiotic-
free serum-containing medium and incubated for 5 h. Cells
were further incubated for a total of 30 h after-transfection
after addition of 2mL of media containing 10% FCS.
2.4. Western Blotting. 30 h after-transfection, cells were
washed twice with 1mL of PBS and harvested in 1mL of PBS
by centrifugation at 2000 rpm for 5min. Whole-cell lysates
were prepared in 70𝜇L of radioimmuno precipitation assay
buffer, RIPA (150mM NaCl, 10mM Tris-HCl pH 7.4, 1%
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Figure 1: Sequence comparison between pGFP-F2A
20
-CherryFP and pGFP2AGUS constructs. While the downstream genes were different
(CherryFP or GUS, resp.), both constructs had the same upstream GFP gene and F2A of 20aa. The only difference was in the sequence
immediately upstream of F2A due to different restriction sites introduced for the specific cloning purposes.
Triton X-100, 1% Na deoxycholate, 0.1% SDS), and freshly
added 1/20 volume of EDTA-free protease inhibitor cocktail
(Sigma) by incubation on ice for 30min and centrifugation
at 12000 rpm for 20min at 4∘C. Cellular debris was discarded
and supernatants containing proteins were analysed by 12%
SDS-PAGE. The proteins were then transferred to a nitro-
cellulose membrane, which was probed with anti-GFP or
anti-CherryFP primary antibodies overnight, after blocking
in PBST containing 5% milk for 1 h. Following overnight
incubation, themembranes werewashed three times in PBST.
Detection of bound primary antibodies was performed with
respective HRP-conjugated secondary antibodies (Dako), in
PBST containing 5% milk for 1 h. The membranes were
washed three times with PBST, rinsed in deionised water,
and subjected to enhanced chemiluminescence by incubating
the membranes in freshly prepared visualisation solution for
2min. The membranes were exposed to an autoradiograph
film for 3 to 45 seconds.
3. Results
3.1. Substitutions Immediately Upstream of F2A (20aa Version;
F2A
20
): Effect on Cleavage Efficiency. Previously we showed
that the 20aa version of F2A encoded by pGFP2AGUS was
highly active [8, 27]. Indeed, this version has been used
widely in other laboratories. To our surprise, the cleavage
activity observed for the same length of F2A used to link
GFP and CherryFP (pGFP-F2A
20
-CherryFP) was noticeably
lower (Figures 1 and 2(c)). The upstream GFP and the F2A
(20aa) were identical in both constructs: the only difference
was the short “linker” between GFP and F2A created by
the cloning strategy: -RAKRSLE- (pGFP-F2A
20
-CherryFP;
linker derived from furin and XhoI restriction site) and -
SGSRGAC- (pGFP2AGUS; linker derived from XbaI and
SphI restriction sites), with only the arginine (shown in bold
type face) in common (Figure 1).
To investigate the reason underlying the different cleav-
age activities, we produced a set of three pGFP-F2A
20
-
CherryFP mutant constructs in which the sequence of
this linker was converted, stepwise (changed residues
underlined), to the pGFP2AGUS linker sequence: mut1 (-
RAKRSLE- substituted to -SGSRSLE-), mut2 (-RAKRSLE-
to -RAKRGAC-), and mut3 (-RAKRSLE- to -SGSRGAC-)
with the mut3 sequence being identical to that of the more
active pGFP2AGUS sequence (Figures 1 and 2(a)). Coupled
transcription/translation analyses using in vitro systems
produced five translation products. The major translation
products corresponded to proteins of predicted molecu-
lar weights: uncleaved [GFP-F2A
20
-CherryFP] and the two
cleavage products, [GFP-F2A
20
] and CherryFP, the latter
two products comigrating on the gel due to similar mass
(Figure 2(b)). The ratio of the cleaved : uncleaved products
was higher inmutants 2 and 3, demonstrating higher cleavage
activity in these constructs. Translation profiles derived from
all four constructs also showed a certain level of internal
initiation within GFP, producing the N-terminally truncated
cleavage product [ΔGFP-F2A]. On the basis of the molec-
ular mass of the product and distribution of methionine
codons within GFP, we assume that this low-level internal
initiation occurred at Met88—in a favourable Kozak context
(cCAUGc). There was also a slower migrating band, corre-
sponding to a protein of ∼45 kDa, which was also present in
western blots (Figure 2(c), indicated with an asterisk). This
minor product was detected by anti-GFP (Figure 2(c), upper
blot) but not anti-CherryFP antibodies (Figure 2(c), middle
blot). The nature of this minor product is the subject of
further characterisation. As expected, the upstream [GFP-
F2A] cleavage product was detected by anti-GFP but not
anti-CherryFP antibodies (Figure 2(c), upper blot), whilst
the downstream CherryFP product was detected by anti-
CherryFP but not anti-GFP, antibodies (Figure 2(c), middle
blot).
Data obtained from both in vitro translation and in vivo
(transfected HeLa cells) using these four constructs showed
that in the case of pGFP-F2A
20
-CherryFP, introduction of
the -SGS- substitution (mut1) somewhat improved cleavage
activity. Introduction of either the -GAC- substitution adja-
cent to the N-terminus of F2A (mut2) or the -SGSRGAC-
substitution (mut3) resulted, however, in considerably higher
cleavage activity, demonstrated by the increased ratio of
cleaved : uncleaved products (more evident in western blots
with extended exposures; Figures 2(b) and 2(c)).
3.2. Substitutions Immediately Upstream of F2A (25–18aa
Versions): Effect on Cleavage Efficiency. To investigate if
such substitutions would affect the cleavage efficiency
of constructs encoding longer versions of F2A (Table 1),
we substituted the -RAKRSLE- linker with -SGSRGAC-.
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Figure 2: Effect of various substitutions, introduced in the region immediately upstream of F2A, on cleavage efficiency of [GFP-F2A
20
-
CherryFP] polyproteins. (a) Amino acid sequence comparison (mutated residues are boxed) of parental pGFP-F2A
20
-Cherry (wt) and three
mutant pGFP-F2A
20
-Cherry constructs (mut1, mut2, and mut3) used to coexpress GFP and CherryFP proteins from a single ORF in vitro
using coupled transcription/translation rabbit reticulocyte lysate system (b) and transfected HeLa cells (c). For TnT, reticulocyte lysates were
programmed with 20 ng of plasmid DNA, and translation products were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa cells were
transfected with 1.5 𝜇g of plasmid DNA and harvested 30 h after transfection. Cells were lysed in RIPA buffer, and equal amounts of total
protein for each transfection were loaded onto 12% SDS-PAGE gel. The proteins were transferred onto a nitrocellulose membrane, blocked
in PBS containing 5% milk and probed with anti-GFP (upper blot) and anti-CherryFP (middle blot) antibodies overnight at 4∘C. Detection
of bound primary antibody was achieved by using respective secondary antibodies, followed by ECL detection. All experiments were done
in triplicate.
The effects of amino acid substitutionswere determined using
translation in vitro and inHeLa cells transfected with plasmid
DNAs andwestern blotting (Figures 3(b) and 3(c)).The cleav-
age activity (ratio of cleaved : uncleaved forms) of all mutant
constructs was higher (more apparent in western blots with
extended exposures (see Figure S1)). This difference was
not as significant in longer versions (24/25aa) compared to
shorter versions (18/20/21aa): the cleavage activity of the
shortest version (18aa) was the most “improved.” Overall,
the improved mutant constructs with resulting high cleavage
efficiency followed the previously described “cleavage pat-
tern” [27] and Minskaia et al., manuscript in preparation,
where stepwise amino acid deletions from the N-terminus of
F2A resulted in linear increase in accumulation of uncleaved
polyprotein and a decrease in the amounts of cleaved pro-
ducts (Figure 4). This pattern, however, was changed in
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Figure 3: Effect of -RAKRSLE- to -SGSRGAC- substitution immediately upstream of F2A on cleavage efficiency of pGFP-F2A-Cherry
constructs with F2As of 25–18aa. Parental pGFP-F2A-Cherry constructs and their mutant versions (mut or Fmut) (mutated residues are
boxed, (a)) were used to coexpress GFP and CherryFP proteins from a single ORF in vitro using coupled transcription/translation rabbit
reticulocyte lysate system (b) and transfected HeLa cells (c). For TnT, reticulocyte lysates were programmed with 20 ng of plasmid DNA, and
translation products were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa cells were transfected with 1.5𝜇g of plasmid DNA and
harvested 30 h after transfection. Cells were lysed in RIPA buffer, and equal amounts of total protein for each transfection were loaded onto
12% SDS-PAGE gel. The proteins were transferred onto a nitrocellulose membrane, blocked in PBS containing 5% milk, and probed with
anti-GFP (upper blot) and anti-CherryFP (middle blot) antibodies overnight at 4∘C. Detection of bound primary antibody was achieved by
using respective secondary antibodies, followed by ECL detection. All experiments were done in triplicate.
the case of the construct with the shortest version of F2A
(pGFP-F2A
18mut-CherryFP), as it was more efficient at cleav-
age, compared to pGFP-F2A
20mut-CherryFP, judging by the
decrease in the amount of uncleaved polyprotein and increase
in the amounts of both [GFP-F2A] and CherryFP detected
by the appropriate antibodies. Finally, we noticed that the
cleaved [GFP-F2A] products of parental constructs migrated
more slowly on the gel compared to those from the mutant
constructs (Figure 3(c)). Substitution of the -SGSRGAC-
(637Da) by -RAKRSLE- (859Da) decreased the molecular
weight of mutant cleavage products by more than 200Da.
In order to more finely map the effect of these muta-
tions, the -RAKR- motif within the 18 and 20aa versions of
pGFP-F2A-CherryFP (encoding the least active F2As) was
mutated to -AAKA-, producing pGFP-F2A
20Fm-CherryFP
and pGFP-F2A
18Fm-CherryFP (Figures 3(a) and Table 1).
Interestingly, the cleavage activity for the pGFP-F2A
18Fm-
CherryFP construct was as low as that of the parental
pGFP-F2A
18
-CherryFP construct, demonstrating that the
improved cleavage efficiency of pGFP-F2A
18mut-CherryFP
with -SGSRGAC- substitution was, therefore, attributable to
the nature of the linker sequence (Figures 3(c) and Table 1).
On the contrary, introduction of the -AAKA- substitution
in the F2A
20
construct resulted in an increase in cleavage
efficiency comparable to that of the mutant construct pGFP-
F2A
20mut-CherryFPwith the -SGSRGAC- substitution.These
results demonstrate that the difference in the 2 residues at the
N-terminus of F2A (pGFP-F2A
20Fm-CherryFP versus pGFP-
F2A
18Fm-CherryFP), together with the difference in the 3
residues immediately upstream of F2A (-SGSRGAC- versus
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Figure 4: Efficiency of F2A cleavage in pGFP-F2A-CherryFP “mutants” with -SGSRGAC- substitution immediately upstream of F2A of
25–18aa. pGFP-F2A-CherryFP “mutant” constructs were used to coexpress GFP and CherryFP proteins from a single ORF in transfected
HeLa cells. The cells were transfected with 1.5𝜇g of plasmid DNA and harvested 30 h after transfection. Cells were lysed in RIPA buffer, and
equal amounts of total protein for each transfection were loaded onto 12% SDS-PAGE gel. The proteins were transferred onto a nitrocellulose
membrane, blocked in PBS containing 5%milk, and probedwith anti-GFP (upper blot) and anti-CherryFP (middle blot) antibodies overnight
at 4∘C. Detection of bound primary antibody was achieved by using respective secondary antibodies, followed by ECL detection. All
experiments were done in triplicate.
-AAKASLE- in the F2A
18
construct), can have a profound
effect on cleavage efficiency in the case of these short F2As
(Figures 3(c) and Table 1).
3.3. Introduction of Mutations Immediately Upstream of T2A
May Decrease Activity. The T2A sequence (18aa) is highly
active and has not been reported to be susceptible to the
nature of the C-terminus of the upstream gene. To test if
T2A was susceptible to substitutions immediately upstream,
we introduced “reverse” substitutions (mut1: MHSRGSG-
to -MHSRSLE- and mut2: -MHSRGSG to -RAKRSLE-) in
the same [GFP-2A-CherryFP] context (Figures 5(a) and
Table 1).The effect on cleavage activity was determined using
reticulocyte lysate in vitro translation systems (Figure 5(b))
and transfected HeLa cells (Figure 5(c)). These substitutions
resulted in decreased cleavage activity in both mutant
constructs, more apparent in HeLa cells than in reticulocyte
lysates, as detected by both anti-GFP (Figure 5(c), left
blot) and anti-CherryFP (Figure 5(c), right blot) antibodies.
Introduction of the -SLE- substitution immediately upstream
of T2A (mut1; Table 1) had even greater effect on activity than
the -RAKRSLE- substitution (mut2; Table 1; Figure 5(c)).
Again, this observation reveals the importance of the
3 residues immediately upstream of such short F2As. It is
worth noting that in our parental construct, the -MHSRGSG-
sequence comprises 3 restriction sites used for cloning (NsiI,
XbaI, and BspEI). Coincidentally, a -GSG- linker motif
was recently shown to improve cleavage efficiency ([12, 34],
discussed below).
3.4. Comparison of Cleavage Efficiencies of “Improved” Short
F2As and T2A. As a last step in optimisation of the F2A
system, we compared cleavage efficiencies of the most active
F2A- and T2A-based constructs (F2A
30
, F2A
20mut3, F2A18mut,
and T2Awt) in HeLa cells (Figure 6). Two major products
corresponding to proteins of expected molecular weights,
uncleaved [GFP-2A-CherryFP] polyprotein and the two
cleavage products, [GFP-2A] and CherryFP, were detected
by western blot analysis with both anti-GFP (Figure 6, upper
blot) and anti-CherryFP (Figure 6, middle blot) antibodies.
The cleavage efficiency of the F2A
30
version, shown to be
highly efficient F2A (Minskaia et al., manuscript in prepa-
ration), was comparable to that of the T2Awt- and T2Amut2-
versions, with virtually no uncleaved polyprotein present
in HeLa cells. Substitutions immediately upstream of T2A
(T2Amut2) resulted in decreased coordinate expression of
both genes. This construct was still highly active compared
to F2A20wt- and F2A18wt-based versions with identical amino
acids immediately upstream of F2A. Their substitution to
the more efficient F2A20mut3- and F2A18mut-based constructs
resulted in significant increase in the proportion of cleaved
products. Some uncleaved product was, however, observed
in HeLa cells transfected with these constructs.
4. Discussion
Themodel for 2A-mediated cleavage predicts that the nascent
2A interacts with the exit tunnel of the ribosome to affect
the conformational space occupied by the ester bond linking
the nascent protein and tRNAgly in the ribosome P-site. The
model predicts, therefore, that residues that may influence
activity reside within the exit tunnel of the ribosome [35–
37]. Ours and others, data indicate that in the case of F2A
this interaction with the tunnel occurs along the entire length
of F2A, whereas in the case of T2A it appears that the net
effect of this tunnel interaction is accomplished by a shorter
tract. This notion is supported by our recent data (Minskaia
et al., manuscript in preparation) in which we show that the
cleavage activity of F2As of 30aa (and longer) was insensitive
to theC-terminal sequence of the upstream gene. StepwiseN-
terminal amino acid deletions resulted, however, in dramat-
ically decreased cleavage efficiencies. Taken together, these
observations were consistent with structural data showing
that the ribosome exit tunnel may accommodate 30–40
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Figure 5: Effect of “reverse” substitutions, immediately upstream of T2A, on cleavage efficiency of pGFP-T2A-CherryFP constructs. (a)
Amino acid substitutions introduced in pGFP-T2A-CherryFP sequence immediately upstream of T2A. Mutated residues are shown in bold,
and T2A sequence is underlined. Parental construct pGFP-T2A-CherryFP with -MHSRGSG- linker (wt) and its mutant versions with -
MHSRSLE- and -RAKRSLE- substitutions (T2Amut1 andT2Amut2, resp.) were used to coexpressGFP andCherryFP proteins froma singleORF
in vitro using coupled transcription/translation rabbit reticulocyte lysate system (b) and in transfected HeLa cells (c). For TnT, reticulocyte
lysates were programmedwith 20 ng of plasmidDNA, and translation products were resolved by the 12% SDS-PAGE. For in vivo studies, HeLa
cells were transfected with 1.5𝜇g of plasmid DNA and harvested 30 h after transfection. Cells were lysed in RIPA buffer, and equal amounts
of total protein for each transfection were loaded onto 12% SDS-PAGE gel. The proteins were transferred onto a nitrocellulose membrane,
blocked in PBS containing 5%milk, and probedwith anti-GFP (left blot) and anti-CherryFP (right blot) antibodies overnight at 4∘C.Detection
of bound primary antibody was achieved by using respective secondary antibodies, followed by ECL detection. All experiments were done
in triplicate.
amino acids [38]. The activity of shorter (25–18aa) forms
of F2A may, therefore, be affected by the nature of the C-
terminal sequence of the protein upstream since this region
would now lie within the exit tunnel of the ribosome and
affect its interaction with F2A.
The aim of this study was to further characterise and
improve the efficiency of the 2A coexpression system by
introducing various mutations immediately upstream of
shorter versions of F2A and T2A linking GFP and CherryFP
proteins. Based on the results obtained in vitro in reticulocyte
lysates and in HeLa cells transfected with plasmid DNAs,
we demonstrate that introduction of the -SGS- substitution
(mut1) 4 amino acids upstream of 20aa—long F2A slightly
improved cleavage efficiency, while introduction of either
-GAC- substitution adjacent to the N-terminus of F2A
(mut2, Table 1) or -SGSRGAC- substitution (mut3, Table 1)
immediately upstream of F2A resulted in considerably higher
cleavage efficiencies (Figures 2(b) and 2(c)).
We further demonstrate that in the case of the shortest
F2As (21/20/18aa), substitution of the parental -RAKRSLE-
sequence with -SGSRGAC- greatly improved cleavage effi-
ciencies (Figures 3(a)–3(c), 4, and Table 1), an effect some-
what less evident in the case of longer F2As (25/23aa). The
18aa version, which showed relatively low activity, was dra-
matically improved by the introduction of these mutations.
This increase in activity may be attributed to the -SLE-
to -GAC- exchange since the (furin linker) -RAKR- to -
AAKA- exchange had no detectable effect. However, in the
case of the 20aa version, identical substitutions within either
portion of the linker (-RAKR/SLE-) only slightly increased
activity (Figure 3(c)). Introduction of either -SGSRGAC- or
-AAKASLE- substitutions in the 20aa F2A version resulted
in comparable increase in the cleavage activity. These results
show that just 2aa at the N-terminus of “suboptimal” 2As
(F2A
20
, F2A
18
), and the 3 residues immediately upstream of
2A (F2A18mut versus F2A18Fm), can have a profound effect on
F2A cleavage efficiency (Figure 7). We further showed that
introduction of the “reverse” substitutions of -MHSRGSG-
to -MHSRSLE- (mut1, Table 1) and to -RAKRSLE- (mut2,
Table 1) in the highly active T2A-based construct resulted in
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Figure 6: Efficiency of cleavage in constructs with short 2A sequen-
ces. pGFP-2A-CherryFP constructs with F2As 30wt, 20wt, 20mut3,
18wt, 18mut, and T2Awt and T2Amut2 were used to coexpress GFP
and CherryFP proteins from a single ORF in transfected HeLa
cells. The cells were transfected with 1.5𝜇g of plasmid DNA, and
harvested 30 h after transfection. Cells were lysed in RIPA buffer,
and equal amounts of total protein for each transfection were loaded
onto 12% SDS-PAGE gel. The proteins were transferred onto a
nitrocellulose membrane, blocked in PBS containing 5% milk, and
probed with anti-GFP (upper blot) and anti-Cherry (middle blot)
antibodies overnight at 4∘C. Detection of bound primary antibody
was achieved by using respective secondary antibodies, followed by
ECL detection. All experiments were done in triplicate.
decreased cleavage activity in bothmutant constructs (Figures
5(a)–5(c)). Again, these data highlight the importance of
the 3aa immediately upstream of T2A (in this instance).
Finally, we show that cleavage efficiencies of F2A
30
-, T2Awt-,
and T2Amut2-based constructs were similar, with virtually
no uncleaved form present in HeLa cells (Figure 6). While
introduction of the “reverse” substitutions upstream of T2A
resulted in decreased coordinate expression of both genes
(T2Amut2), it was still highly active compared to F2A20wt
and F2A18wt with identical upstream residues. Their substi-
tution to more “optimal,” F2A20mut3 and F2A18mut, resulted
in significant increase in the amounts of cleaved products.
The presence of some uncleaved translation product does
not, however, compare favourably with the “high-cleavers”
F2A30wt and T2Awt.
The data presented here is in agreement with previously
published studies that successfully used F2A sequences of
various lengths in in vitro and in vivo heterologous systems
[24, 25, 27–29, 31]. To avoid using longer F2A sequences
that remain attached at the C-terminus of the upstream
protein, researchers have used shorter F2As but have reported
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Figure 7: Location of key substitutions that affect 2A cleavage
activity. Amino acid sequence comparison of parental pGFP-F2A
20
-
CherryFP (F2A20wt) and pGFP-F2A18-CherryFP (F2A18wt) and their
corresponding mutant derivatives (F2A20mut and F2A20Fm, F2A18mut,
and F2A18Fm) used to coexpress GFP and CherryFP proteins from
a single ORF (F2A sequence in italics). Mutated residues are boxed,
and cleavage activities are indicated by “−” or “+”.
a range of cleavage activities for F2As of the same length
[9, 12, 24, 27, 28, 39]. Klump and colleagues [40] coexpressed
the homeobox transcription factor along with GFP [GFP-
F2A
24
-HoxB4]. The 24aa version of F2A produced small
amounts of uncleaved translation product in cells—similar
to the data we present here. Based on this work, Milsom and
colleagues [41] first tested two constructs, pHoxB4-2A-GFP
andpMGMT-2A-GFP, coexpressingHoxB4 andMGMT(O6-
methylguanine-DNA-methyl-transferase, a transgene that
conveys chemoresistance) with GFP and noted that in cells
transfected with these constructs the amount of uncleaved
[MGMT-F2A
24
-GFP] polyprotein was far greater than that of
[HoxB4-F2A
24
-GFP]. Noting that the C-terminal sequence
of the upstream protein could be the reason for decreased
cleavage efficiency, a tricistronic retroviral vector pHoxB4-
F2A
24
-MGMT-IRES-GFP was developed to simultaneously
coexpress the three proteins in transfected bone marrow.
WithHoxB4 as the upstream gene, this tricistronic vector was
concluded to be the best for coexpression of both genes, with
insignificant amount of uncleaved polyprotein [41]. Similarly,
using a 24aa version of F2A, de Felipe andRyan [39] produced
a series of constructs for coexpression of various fluores-
cent proteins (some including internal cotranslational signal
sequences). Uncleaved polyprotein was detected, particularly
for constructs encoding proteins targeted to the exocytic
pathway [39]. This lowering of activity was attributed to
interaction of the nascent peptide with the translocon pore
(Sec61 complex) also affecting the interaction of F2A with
the ribosome exit tunnel [33]. In the case of proteins targeted
to enter the exocytic pathway, successful utilization of a 24aa
version F2A with a furin cleavage site immediately upstream
was reported by several groups [24, 32].
This approach was used to link the antibody heavy and
light chain sequences to engineer a mAb expression cassette
that, in the context ofAAV-mediated gene transfer, resulted in
high levels of full-length, functional monoclonal antibodies
in vitro and in vivo [28]. Using the same strategy, significant
antitumour responses have been observed in the clinic using
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monoclonal antibodies that block immune checkpoints by
coexpressing CTLA-4 heavy and light chains [42], while
Camper and colleagues [32] designed a retroviral vector for
the expression of a target Fab’ fragment as a single polyprotein
and showed equimolar expression and processing of the light
and truncated heavy chain domains [32].
As for shorter F2As, different cleavage activities (depend-
ing on protein arrangement) were observedwhenGFP, EGFP,
and hrGFP were coexpressed with cytochrome P450 2B1
(CYP2B1) using a 20aa version of F2A [43]. With a 19aa
version of F2A, cleavage was reported to be less efficient
(70%) for [CFP-F2A
19
-PAC], with some uncleaved polypro-
tein still present [44]. Similar results were achieved when an
18aa version of F2A was used for the generation of retroviral
vectors [45]. Ma and Mitra [46] used even shorter F2A of
17aa to coexpress GUS and CAT proteins (in alternative
gene orders) in planta and demonstrated that [GUS-F2A
17
-
CAT] and [GUS-F2A
17
-GUS] were cleaved to completion,
while [CAT-F2A
17
-GUS] was not. They concluded that the
difference in cleavage efficiencywas due to different upstream
genes. In light of our experiments, however, it is noteworthy
to mention that, based on the data provided, these constructs
also differed in the sequence immediately upstream of 2A:
-QQGGKQVD- for GUS-F2A
17
and -EWQGGAVD- for
CAT-F2A
17
[46].
Interestingly, cleavage efficiency of shorter F2As in dif-
ferent contexts was shown to be improved by insertion of
various spacer sequences, such as -SGS- or -GSG- [12, 34, 47,
48], the V5 epitope tag (-GKPUPNPLLGLDST-) [24], or a
3xFlag epitope tag [31] immediately upstream of F2A. It has
been reported that in 𝛾-retroviral constructs, expression of
multiple genes linked with F2A peptides was facilitated by a
spacer sequence (-SGSG- or -GSG-) immediately upstream
of F2A
22
[12, 34], while Yang and colleagues [24] tested both
these spacers plus the V5 tag which acted, in this context,
as a spacer. In these studies, lentiviral vectors expressing
two-gene T-cell receptors directed against the melanoma
differentiation antigens gp100 andMART-1 were constructed
using F2A
24
. The addition of spacer sequences was, how-
ever, shown to be a prerequisite for efficient synthesis and
assembly of biologically active T-cell receptor complexes.
Interestingly, when the spacer sequence in the form of V5
tag was inserted between furin and F2A
24
, this increased
activity and yielded optimal TCR expression in transduced
lymphocytes. At the same time, attempts to substitute the V5
peptide with other sequences were unsuccessful, suggesting
that the specific amino acid sequence of the V5 tag was
responsible for enhanced ribosomal skipping in this context
[24]. Recently, Tan and colleagues [31] successfully used a
similar strategy by providing a spacer in the form of 3xFlag
tag repeats (incorporated for other purposes) upstream of
an 18aa version of F2A to express double or triple copies of
the rabies virus glycoprotein from a single ORF in human
adenovirus 5 (linked via F2As and followed by hrGFP as a
marker after IRES).
Comparing the activity of 2As of different origins, Don-
nelly and colleagues [27] showed that T2A
20
has the
highest cleavage efficiency followed by E2A
20
, P2A
19
, and
F2A
20
, while Szymczak and colleagues [12] demonstrated
that F2A
22
(-GSG- or -SGSG- upstream) and T2A
18
have
higher activities than E2A
20
. Funston and colleagues [29]
reported that in the case of protein IX, essential for the
packaging of full-length adenoviral genomes and selected
as a fusion partner for coexpression of foreign genes in
adenoviruses, [IX-F2A
58
-GFP] showed a higher activity than
[IX-P2A
22
-GFP]. E2A, T2A, and P2A were successfully used
to generate iPS cells from somatic cells by simultaneous
lentiviral vector transduction of four transcription factors in
a [KLF4-E2A
20
-OCT3/4-T2A
18
-SOX2-P2A
19
-c-Myc]-IRES-
hrGFP construct [20]. Recently, Kim and colleagues [49]
evaluated cleavage efficiency of P2A
19
, T2A
18
, E2A
20
, and
F2A
22
preceded by a -GSG- spacer in a [GFP-2A-CherryFP]
context in three commonly used cell lines, zebrafish embryos,
and adult mice, and concluded that P2A
19
had the highest
cleavage efficiency followed by T2A
18
, E2A
20
, and F2A
22
.
5. Conclusions
2A sequences have enabled more complex strategies of coex-
pression and transgenesis and have been used in many labo-
ratories with highly successful results. Based on the data
presented here and from previous studies, the variations in
cleavage activity of the various lengths of F2As are attributed
to the nature of the region immediately upstream of F2A
(18–30aa upstream of the cleavage site), altered by residues
introduced by the cloning strategy, or, by the introduction
of spacer sequences. Indeed, in the case of the highly active
T2A, changes in this region can result in a decrease of cleavage
efficiency. Such variations in cleavage activity can, however,
be manipulated to great purpose to produce “molecular
rheostats.”
In a very elegant series of experiments, Yu and colleagues
produced a range of truncated and point-mutated forms of
F2A and I2A (from the insect infectious flacherie virus) to
regulate the ratio of surface-anchored to secreted forms of
the immunoglobulin IgG [50]. The data presented in this
paper (together with others), therefore, aids the design (and
troubleshooting) of coexpression strategies but also serves to
show how manipulation of these sequences can be used in
expanding the range of such molecular rheostats.
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